The favorable prognostic effect of tapasin was independently maintained in multivariate analysis when adjusting for potential confounder factors such as patient age and gender, tumor grade, pT, tumor size and location, and adjuvant therapy (p = 0.021). Here, TAPBP is linked to neoplasm.